Preoperative CD4+CD25+/CD4+ and tumor diameter predict prognosis in male patients with bladder cancer.
Conclusion: The combining predictor could be a significant predictor for advanced stage, OS and recurrence probability in male patients with BC.
PMID: 31631674 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | CT Scan | Internal Medicine | Statistics | Urography